benfovir AG is a pharmaceutical company based in Darmstadt in Hesse that specializes in the therapy of viral infections such as the SARS-CoV-2 virus. At this stage, one compound is under clinical development. This compound inhibits the sugar metabolism in infected cells by disabling the formation of the crucial building blocks for virus production (ribose-5-phosphate and acetyl-CoA), and at the same time by preventing the overshooting of the immune system.
Industry
Pharmaceutical Manufacturing, Scientific Research and Development Services, Services
HQ Location
Gräfenhäuserstrasse 26
Darmstadt, Hesse 64293, DE
Keywords
crucial buildingsugar and lipidkey building blocks